Co‐expression pattern of SLC transporter genes associated with the immune landscape and clinical outcomes in gastric cancer

RBPMS2, as a novel biomarker for predicting lymph node metastasis, guides therapeutic regimens in gastric cancer

(2022) Han Zhao et al.   Human Cell

A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer

(2022) Chen Yang et al.   eLife

SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans

(2022) Xuemei Liu et al.   CELLULAR ONCOLOGY

Cross talk between acetylation and methylation regulators reveals histone modifier expression patterns posing prognostic and therapeutic implications on patients with colon cancer

(2022) Rui Zhou et al.   Clinical Epigenetics

Exploration of hub genes, lipid metabolism, and the immune microenvironment in stomach carcinoma and cholangiocarcinoma

(2022) Yuda Gong et al.   Annals of Translational Medicine

Retraction Note: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway

(2022) Jia-Xing Zhang et al.   Molecular Cancer

Expression pattern of secretory‐cell‐related transcriptional signatures in colon adenocarcinomas defines tumor microenvironment characteristics and correlates with clinical outcomes

(2022) Rui Zhou et al.   Molecular Oncology

Solute carriers as potential oncodrivers or suppressors: their key functions in malignant tumor formation

(2021) Khalid Rashid et al.   DRUG DISCOVERY TODAY

Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy

(2021) Kathrin Davari et al.   Journal for ImmunoTherapy of Cancer

Combining gene expression signature with clinical features for survival stratification of gastric cancer

(2021) Qiang Sun et al.   GENOMICS

Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics

(2021) Yoshikatsu Kanai   PHARMACOLOGY & THERAPEUTICS

Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients

(2021) Zheng Xiao et al.   Journal of Immunology Research

CLIP-170S is a microtubule +TIP variant that confers resistance to taxanes by impairing drug-target engagement

(2021) Prashant V. Thakkar et al.   DEVELOPMENTAL CELL

Solute carrier proteins and c-Myc: a strong connection in cancer progression

(2020) Suman Panda et al.   DRUG DISCOVERY TODAY

Top 10 Challenges in Cancer Immunotherapy

(2020) Priti S. Hegde et al.   IMMUNITY

Identification of a novel immune prognostic model in gastric cancer

(2020) Y. Li et al.   Clinical & Translational Oncology

Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy

(2020) Weimin Wang et al.   MOLECULAR CELL

Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates

(2020) Nan Wang et al.   CELL

Burden of Gastric Cancer

(2019) Aaron P. Thrift et al.   Clinical Gastroenterology and Hepatology

Roles of E-cadherin and Noncoding RNAs in the Epithelial–mesenchymal Transition and Progression in Gastric Cancer

(2019) Irina V. Bure et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease

(2019) Tina Schumann et al.   PHARMACOLOGICAL REVIEWS

Solute carrier transporters: the metabolic gatekeepers of immune cells

(2019) Wenxin Song et al.   Acta Pharmaceutica Sinica B

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

(2018) Peng Jiang et al.   NATURE MEDICINE

Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity

(2017) Wen Ye et al.   Cell Death & Disease

Molecular classification of gastric cancer

(2016) N.-Y. Chia et al.   ANNALS OF ONCOLOGY

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

(2016) Willy Hugo et al.   CELL

Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer

(2016) Takaaki Shimakata et al.   HISTOPATHOLOGY

Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma

(2016) M. BRISAM et al.   ONCOLOGY REPORTS

A Call for Systematic Research on Solute Carriers

(2015) Adrián César-Razquin et al.   CELL

Clinical significance of accurate identification of lymph node status in distant metastatic gastric cancer

(2015) Rui Zhou et al.   Oncotarget

Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer

(2013) R. Polanski et al.   CLINICAL CANCER RESEARCH

Solute carriers (SLCs) in cancer

(2013) Sara El-Gebali et al.   MOLECULAR ASPECTS OF MEDICINE

The SLC16 gene family – Structure, role and regulation in health and disease

(2013) Andrew P. Halestrap   MOLECULAR ASPECTS OF MEDICINE

The ABCs of membrane transporters in health and disease (SLC series): Introduction

(2013) Matthias A. Hediger et al.   MOLECULAR ASPECTS OF MEDICINE

Mutational heterogeneity in cancer and the search for new cancer-associated genes

(2013) Michael S. Lawrence et al.   NATURE

Trends in the exploitation of novel drug targets

(2011) Mathias Rask-Andersen et al.   NATURE REVIEWS DRUG DISCOVERY

A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups

(2008) S. Sulong et al.   BLOOD